Liraglutide and Exercise Synergistically Attenuate Vascular Inflammation and Enhance Metabolic Insulin Action in Early Diet-Induced Obesity
Open accessPublished version of a preprint
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Inflammation-induced vascular insulin resistance is an early event in diet-induced obesity and contributes to metabolic insulin resistance. To examine whether exercise and glucagon-like peptide 1 (GLP-1) receptor agonism, alone or in combination, modulate vascular and metabolic insulin actions during obesity development, we performed a euglycemic insulin clamp in adult male rats after 2 weeks of high-fat diet feeding with either access to a running wheel (exercise), liraglutide, or both. Rats exhibited increased visceral adiposity and blunted microvascular and metabolic insulin responses. Exercise and liraglutide alone each improved muscle insulin sensitivity, but their combination fully restored insulin-mediated glucose disposal rates. The combined exercise and liraglutide intervention enhanced insulin-mediated muscle microvascular perfusion, reduced perivascular macrophage accumulation and superoxide production in the muscle, attenuated blood vessel inflammation, and improved endothelial function, along with increasing endothelial nucleus translocation of NRF2 and increasing endothelial AMPK phosphorylation. We conclude that exercise and liraglutide synergistically enhance the metabolic actions of insulin and reduce vascular oxidative stress and inflammation in the early stage of obesity development. Our data suggest that early combination use of exercise and GLP-1 receptor agonism might be an effective strategy in preventing vascular and metabolic insulin resistance and associated complications during the development of obesity. Article Highlights: Inflammation-induced vascular insulin resistance occurs early in diet-induced obesity and contributes to metabolic insulin resistance. We examined whether exercise and GLP-1 receptor agonism, alone or in combination, modulate vascular and metabolic insulin actions during obesity development. We found that exercise and liraglutide synergistically enhanced the metabolic actions of insulin and reduced perimicrovascular macrophage accumulation, vascular oxidative stress, and inflammation in the early stage of obesity development. Our data suggest that early combination use of exercise and a GLP-1 receptor agonist might be an effective strategy in preventing vascular and metabolic insulin resistance and associated complications during the development of obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“There are preclinical data suggesting that GLP-1 therapy and exercise synergistically attenuate vascular inflammation and enhance metabolic insulin action in early diet-induced obesity.84”
From Changes in lean body mass with glucagon‐like peptide ‐1‐based therapies and mitigation strategies (2024) · cites this paper as [84]
In the citing paper
“Aerobic and resistance training exercises also improve insulin sensitivity, vascular function, and oxidative stress, critical for long-term cardiometabolic health [164].”
In the citing paper
“Aerobic and resistance training exercises also improve insulin sensitivity, vascular function, and oxidative stress, critical for long-term cardiometabolic health [172].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 1996 Guide for the Care and Use of Laboratory Animals
Clark, J. D., Gebhart, G. F., Gonder, J. C., Keeling, M. E., & Kohn, D. F. (1997) · ILAR Journal · doi:10.1093/ilar.38.1.41 · Cited by 4,417
Cell Survival Responses to Environmental Stresses Via the Keap1-Nrf2-ARE Pathway
Kensler, T. W., Wakabayashi, N., & Biswal, S. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141046 · Cited by 3,630
Guide for the care and use of laboratory animals
(1997) · Choice Reviews Online · doi:10.5860/choice.34-3310 · Cited by 2,922
DeFronzo, R. A., Gunnarsson, R., Björkman, O., Olsson, M., & Wahren, J. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111938 · Cited by 1,167
Venugopal, R., & Jaiswal, A. K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14960 · Cited by 1,040
le Roux, C. W., Astrup, A., Fujioka, K., Greenway, F., Lau, D. C. W., Van Gaal, L., Ortiz, R. V., Wilding, J. P. H., Skjøth, T. V., Manning, L. S., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30069-7 · Cited by 850
Lillioja, S., Young, A. A., Culter, C. L., Ivy, J. L., Abbott, W. G., Zawadzki, J. K., Yki-Järvinen, H., Christin, L., Secomb, T. W., & Bogardus, C. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113088 · Cited by 782
Nyström, T., Gutniak, M. K., Zhang, Q., Zhang, F., Holst, J. J., Ahrén, B., & Sjöholm, Å. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00237.2004 · Cited by 680
Kim, Y.-B., Nikoulina, S. E., Ciaraldi, T. P., Henry, R. R., & Kahn, B. B. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6928 · Cited by 487
Kim, F., Pham, M., Maloney, E., Rizzo, N. O., Morton, G. J., Wisse, B. E., Kirk, E. A., Chait, A., & Schwartz, M. W. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.169722 · Cited by 364
Barrett, E. J., Eggleston, E. M., Inyard, A. C., Wang, H., Li, G., Chai, W., & Liu, Z. (2009) · Diabetologia · doi:10.1007/s00125-009-1313-z · Cited by 323
Self-citationVincent, M. A., Barrett, E. J., Lindner, J. R., Clark, M. G., & Rattigan, S. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00021.2003 · Cited by 305
Zhang, W.-J., Wei, H., Hagen, T., & Frei, B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700305104 · Cited by 257
Dai, G., Vaughn, S., Zhang, Y., Wang, E. T., Garcia-Cardena, G., & Gimbrone, M. A. (2007) · Circulation Research · doi:10.1161/circresaha.107.152942 · Cited by 245
Exercise‐Induced Capillary Growth in Human Skeletal Muscle and the Dynamics of VEGF
Hoier, B., & Hellsten, Y. (2014) · Microcirculation · doi:10.1111/micc.12117 · Cited by 215
Mixed meal and light exercise each recruit muscle capillaries in healthy humans
Vincent, M. A., Clerk, L. H., Lindner, J. R., Price, W. J., Jahn, L. A., Leong-Poi, H., & Barrett, E. J. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00497.2005 · Cited by 201
KLF2 Primes the Antioxidant Transcription Factor Nrf2 for Activation in Endothelial Cells
Fledderus, J. O., Boon, R. A., Volger, O. L., Hurttila, H., Ylä-Herttuala, S., Pannekoek, H., Levonen, A.-L., & Horrevoets, A. J. G. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.165811 · Cited by 197
Chai, W., Dong, Z., Wang, N., Wang, W., Tao, L., Cao, W., & Liu, Z. (2012) · Diabetes · doi:10.2337/db11-1073 · Cited by 194
Self-citationInsulin regulates its own delivery to skeletal muscle by feed-forward actions on the vasculature
Barrett, E. J., Wang, H., Upchurch, C. T., & Liu, Z. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00186.2011 · Cited by 171
Self-citationChung, A. W. Y., Hsiang, Y. N., Matzke, L. A., McManus, B. M., van Breemen, C., & Okon, E. B. (2006) · Circulation Research · doi:10.1161/01.res.0000232352.90786.fa · Cited by 140
Liu, H.-Y., Hong, T., Wen, G.-B., Han, J., Zuo, D., Liu, Z., & Cao, W. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00374.2009 · Cited by 115
Self-citationJojima, T., Uchida, K., Akimoto, K., Tomotsune, T., Yanagi, K., Iijima, T., Suzuki, K., Kasai, K., & Aso, Y. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.04.001 · Cited by 105
Subaran, S. C., Sauder, M. A., Chai, W., Jahn, L. A., Fowler, D. E., Aylor, K. W., Basu, A., & Liu, Z. (2014) · Clinical Science · doi:10.1042/cs20130708 · Cited by 95
Self-citationKim, Y.-B., Shulman, G. I., & Kahn, B. B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204710200 · Cited by 93
Chai, W., Wang, W., Liu, J., Barrett, E. J., Carey, R. M., Cao, W., & Liu, Z. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.145409 · Cited by 89
Self-citationThe endothelial cell: An “early responder” in the development of insulin resistance
Barrett, E. J., & Liu, Z. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-012-9232-6 · Cited by 88
Self-citationInyard, A. C., Clerk, L. H., Vincent, M. A., & Barrett, E. J. (2007) · Diabetes · doi:10.2337/db07-0020 · Cited by 80
Chai, W., Zhang, X., Barrett, E. J., & Liu, Z. (2014) · Diabetes · doi:10.2337/db13-1597 · Cited by 73
Self-citationWang, N., Tan, A. W. K., Jahn, L. A., Hartline, L., Patrie, J. T., Lin, S., Barrett, E. J., Aylor, K. W., & Liu, Z. (2020) · Diabetes Care · doi:10.2337/dc19-1465 · Cited by 73
Self-citationDong, Z., Chai, W., Wang, W., Zhao, L., Fu, Z., Cao, W., & Liu, Z. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00473.2012 · Cited by 71
Self-citationVascular function, insulin action, and exercise: an intricate interplay
Zheng, C., & Liu, Z. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.02.002 · Cited by 71
Self-citationInflammation-induced microvascular insulin resistance is an early event in diet-induced obesity
Zhao, L., Fu, Z., Wu, J., Aylor, K. W., Barrett, E. J., Cao, W., & Liu, Z. (2015) · Clinical Science · doi:10.1042/cs20150143 · Cited by 63
Self-citationWheatley, C. M., Rattigan, S., Richards, S. M., Barrett, E. J., & Clark, M. G. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00077.2004 · Cited by 61
Diabetes pathogenesis and management: the endothelium comes of age
Love, K. M., Barrett, E. J., Malin, S. K., Reusch, J. E. B., Regensteiner, J. G., & Liu, Z. (2021) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjab024 · Cited by 57
Self-citationChai, W., Fu, Z., Aylor, K. W., Barrett, E. J., & Liu, Z. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00205.2016 · Cited by 51
Self-citationMuscle Insulin Resistance and the Inflamed Microvasculature: Fire from Within
Liu, J., & Liu, Z. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030562 · Cited by 50
Self-citationZhao, L., Fu, Z., Wu, J., Aylor, K. W., Barrett, E. J., Cao, W., & Liu, Z. (2015) · The Journal of Physiology · doi:10.1113/jp270371 · Cited by 50
Self-citationRanolazine recruits muscle microvasculature and enhances insulin action in rats
Fu, Z., Zhao, L., Chai, W., Dong, Z., Cao, W., & Liu, Z. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2013.257246 · Cited by 49
Self-citationPerivascular macrophages in high-fat diet-induced hypothalamic inflammation
Mendes, N. F., & Velloso, L. A. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02519-6 · Cited by 44
Perivascular Macrophages Regulate Blood Flow Following Tissue Damage
Vågesjö, E., Parv, K., Ahl, D., Seignez, C., Hidalgo, C. H., Giraud, A., Amoêdo‐Leite, C., Korsgren, O., Wallén, H., Juusola, G., et al. (2021) · Circulation Research · doi:10.1161/circresaha.120.318380 · Cited by 41
Love, K. M., Liu, J., Regensteiner, J. G., Reusch, J. E. B., & Liu, Z. (2020) · Journal of Diabetes · doi:10.1111/1753-0407.13045 · Cited by 40
Self-citationHepatic Lysosomal iNOS Activity Impairs Autophagy in Obesity
Qian, Q., Zhang, Z., Li, M., Savage, K., Cheng, D., Rauckhorst, A. J., Ankrum, J. A., Taylor, E. B., Ding, W., Xiao, Y., et al. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.03.005 · Cited by 40
Zhao, L., Chai, W., Fu, Z., Dong, Z., Aylor, K. W., Barrett, E. J., Cao, W., & Liu, Z. (2013) · Circulation Research · doi:10.1161/circresaha.111.300388 · Cited by 39
Self-citationAdiponectin and insulin cross talk: The microvascular connection
Zhao, L., Fu, Z., & Liu, Z. (2014) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2014.08.001 · Cited by 38
Self-citationFu, Z., Zhao, L., Aylor, K. W., Carey, R. M., Barrett, E. J., & Liu, Z. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.03025 · Cited by 36
Self-citationWang, N., Chai, W., Zhao, L., Tao, L., Cao, W., & Liu, Z. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00537.2012 · Cited by 33
Self-citationLiu, J., Aylor, K. W., Chai, W., Barrett, E. J., & Liu, Z. (2022) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00240.2021 · Cited by 30
Self-citationTan, A. W. K., Subaran, S. C., Sauder, M. A., Chai, W., Jahn, L. A., Fowler, D. E., Patrie, J. T., Aylor, K. W., Basu, A., & Liu, Z. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2017-00446 · Cited by 24
Self-citationThe vascular endothelium in diabetes and its potential as a therapeutic target
Liu, Z. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9238-8 · Cited by 19
Self-citationScognamiglio, R., Negut, C., de Kreutzenberg, S. V., Palisi, M., Tiengo, A., & Avogaro, A. (2005) · Clinical Cardiology · doi:10.1002/clc.4960280210 · Cited by 10
Insulin-mediated muscle microvascular perfusion and its phenotypic predictors in humans
Love, K. M., Jahn, L. A., Hartline, L. M., Patrie, J. T., Barrett, E. J., & Liu, Z. (2021) · Scientific Reports · doi:10.1038/s41598-021-90935-8 · Cited by 8
Self-citation
Cited by
Changes in lean body mass with glucagon‐like peptide ‐1‐based therapies and mitigation strategies
Neeland, I. J., Linge, J., & Birkenfeld, A. L. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15728 · Cited by 391
Mozaffarian, D., Agarwal, M., Aggarwal, M., Alexander, L., Apovian, C. M., Bindlish, S., Bonnet, J., Butsch, W. S., Christensen, S., Gianos, E., et al. (2025) · The American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2025.04.023 · Cited by 154
Mozaffarian, D., Agarwal, M., Aggarwal, M., Alexander, L., Apovian, C. M., Bindlish, S., Bonnet, J., Butsch, W. S., Christensen, S., Gianos, E., et al. (2025) · Obesity · doi:10.1002/oby.24336 · Cited by 143
Tkaczenko, H., & Kurhaluk, N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031098 · Cited by 80
Skeletal muscle and MASLD: Mechanistic and clinical insights
Marjot, T., Armstrong, M. J., & Stine, J. G. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000711 · Cited by 82
Metadata
- Authors
- Liu, J., Aylor, K. W., & Liu, Z.
- Affiliations
- University of Virginia Health System (US)
- Corresponding author
- Liu, Zhenqi
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2023-04-19
- Volume
- 72
- Issue
- 7
- Pages
- 918-931
- ISSN
- 0012-1797 (ISSN-L)
- PMC
- PMC10281235
- OpenAlex
- W4366351986
- Cited by
- 30
- References
- 51
- Citations by year
- 2026: 5 · 2025: 16 · 2024: 8 · 2023: 1
- FWCI
- 5.97
- Type
- journal article
- Language
- en
- Update notices
- correction (2024-04-23)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (R01DK1124344, R01DK125330)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- liraglutide, physical activity, GLP-1 receptor agonism, diet-induced obesity, vascular insulin resistance, endothelial function, oxidative stress, perivascular macrophages, microvascular blood flow, Nrf2, AMPK, high-fat diet, visceral fat
- MeSH terms
- Glucagon-Like Peptide-1 Receptor, Liraglutide, Animals, Inflammation, Insulin, Insulin Resistance, Male, Obesity, Rats, Diet, High-Fat, Insulin, Regular, Human
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.